Sandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in February

Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report) was the recipient of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 366,500 shares, a drop of 52.6% from the January 31st total of 773,500 shares. Based on an average daily volume of 95,900 shares, the short-interest ratio is currently 3.8 days.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. BNP Paribas cut shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, December 2nd. UBS Group lowered shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Monday, February 3rd.

Sandoz Group Price Performance

Sandoz Group stock traded down $0.03 during mid-day trading on Wednesday, reaching $44.55. 58,605 shares of the company's stock were exchanged, compared to its average volume of 39,895. Sandoz Group has a twelve month low of $27.79 and a twelve month high of $49.81. The company has a fifty day moving average of $45.24 and a 200-day moving average of $43.99.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.